Ars TechnicaCenter·
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
Read at Ars Technica →
Technology · 1 sources covering this
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/2754a7a5970eac77029ee7600ccfc23fb18e1eba" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss"></iframe>
